In response to the recent “FDA Safety Alert Regarding Use of Fecal Microbiota for Transplantation…
MaaT PharmaMarch 13, 2020
Lyon, France, February 5, 2020 – MaaT Pharma announced today an €18 million Series B…
MaaT PharmaJanuary 31, 2020
Lyon, France, November 6, 2019 – MaaT Pharma announced today that a poster will…
nboutaouiNovember 6, 2019
Jean-Marc Renard, MS, MBA, joins as Chief Business Officer Emmanuel Prestat, PhD, joins as Computational…
nboutaouiSeptember 10, 2019
Independent Data Safety Monitoring Board (DSMB) confirms continuation of Phase II HERACLES study in acute…
nboutaouiAugust 13, 2019
Independent Data Safety Monitoring Board (DSMB) confirms continuation of Phase II HERACLES study in acute…
nboutaouiJune 24, 2019
- First patents to cover the fundamental processes for accessing the human gut microbiome as…
nboutaouiMay 21, 2019
“Caelus Health, EnteroBiotix, Ferring Pharmaceuticals, and MaaT Pharma, in coordination with the Pharmabiotic Research Institute…
nboutaouiMay 21, 2019
MaaT Pharma Announces Second Positive DSMB Safety Assessment of Phase II HERACLES Study in Acute…
nboutaouiApril 9, 2019
